EW - Spark Newswire

1 minute read

Truist Securities Maintains Buy on Edwards Lifesciences, Lowers Price Target to $112

Today, 7:04 AM

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $117 to $112.

2 minute read

Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market

By Michael Cohen

Today, 7:04 AM

Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read.

ABT

3 minute read

Important Biotech Catalysts For September 15, 2022 – End Of The Day Summary

By Ragothaman Srinivasan

Today, 7:04 AM

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity…

ALNY

1 minute read

FDA Approves Edwards Lifesciences’ PASCAL Precision Transcatheter Valve Repair System For Most Frequent Cardiovascular Disorder

By Vandana Singh

Today, 7:04 AM

The FDA has approved Edwards Lifesciences Corp’s (NYSE:EW) PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) for degenerative…

2 minute read

Edwards Lifesciences Whale Trades Spotted

By Benzinga Insights

Today, 7:04 AM

Someone with a lot of money to spend has taken a bullish stance on Edwards Lifesciences (NYSE:EW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 minute read

Here’s How Much $100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 7:04 AM

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.8%. Currently, Edwards Lifesciences has a market capitalization of $62.66 billion.